Genomic studies suggest that lymphoma cell proliferation and survival are driven at least in part, by deregulated TLR, BCR, JAK-STAT, and NFκB signaling pathways inducing constitutive NFκB activation43–45. Here, NFKB1 is linked to lymphoma.